Latka logo
ArsenalBio logo

ArsenalBiorevenue & acquisition

South San Francisco, CaliforniaFounded 2019

ArsenalBio was acquired.

ArsenalBio was founded with the mission to discover, develop, and commercialize curative immune cell therapies for solid tumors.

arsenalbio.comLinkedInUpdated Oct 5, 2026
Annual revenue
$72.4M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
327
Dec 2023EST

ArsenalBio revenue

ArsenalBio has not published its revenue. Growjo puts it at about $72.4M a year (December 2023).

$0
$20M
$40M
$60M
$0
–
$72.4M
20192020–222023
ReportedEstimateFounded 2019 at $0; every reading has its own bar
As ofRevenueSource
Dec 2023$72.4MESTGrowjo estimate

Who owns ArsenalBio

Another company owns ArsenalBio. The date and price of the deal are not on record.

ArsenalBio CEO, founders & employees

Ken Drazan founded ArsenalBio in 2019 and led it as CEO. ArsenalBio had 327 employees (December 2023, Growjo estimate).

0
100
200
300
268
327
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 2023327ESTGrowjo estimate
Dec 2022268ESTGrowjo estimate

ArsenalBio FAQ

What was ArsenalBio's revenue?

Growjo estimates ArsenalBio's revenue at about $72.4M a year (December 2023). The company hasn't published its own figure.

How many employees does ArsenalBio have?

Growjo estimates ArsenalBio's headcount at about 327 (December 2023).

Who founded ArsenalBio?

Ken Drazan founded ArsenalBio in 2019.

Categories

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun ArsenalBio? Join the podcast